VRAX (viraxbiolabs.com) Company Cash Volume

Graphic logo of viraxbiolabs.com (VRAX)

An IT platform for optimizing test distribution creates the foundation for growth for Virax Biolabs Group (VRAX). The current cash level on the GURU.Markets chart confirms this potential, where the 0.01 metric serves as the target level. External conditions are determined by the global biosecurity ecosystem featuring digital health passports, although falling demand for rapid diagnostics and the slow launch of new products are weighing on capital.

VRAX - Virax Biolabs Group Ltd Company Liquid Assets over the range 04/28/2023 - 11/21/2026

Analytical breakdowns for Virax Biolabs (VRAX)

- current price and projected stock value:
Comprehensive company analysis:Virax Biolabs Group
Signature product of viraxbiolabs.com

The optimized logistics for express tests at Virax Biolabs Group (VRAX) require the constant maintenance of high liquidity to cover air freight and warehousing operations. This process is digitized through the volume of free funds in accounts, eliminating dependence on external borrowings. This metric measures the actual capital reserve, determining the company's ability to instantaneously settle short-term liabilities. It is critical for investors to monitor the balance between security and resource efficiency. The price action of the cash-on-hand indicator clearly demonstrates the resilience of the financial cushion.

Competing companies

Company Cash on Hand A (Agilent Tech)|Quest Diagnostics - Company Cash and Cash Equivalents|Company Cash Funds Illumina Corp ILMN|Company Liquid Assets Exact Sciences Corporation (EXAS)|RVTY: Company Cash on Hand|BIO: Company Cash Funds|Anbio Biotechnology Ltd (NNNN) - Company Cash Funds|soterahealth.com (SHC) - Company Cash Volume|QDEL (QuidelOrtho Corporation) - Company Cash Volume|OPK: Company Cash Balance|Company Cash Volume CDNA|MRVI: Company Total Cash Volume|Company Cash Volume FLGT (Fulgent Genetics Inc)|Company Total Cash Amount LAB (fluidigm.com)|Cytek Corp - Company Cash Volume|OSUR (OraSure Technologies, Inc.) - Company Cash and Cash Equivalents|Exagen Diagnostics (XGN) - Company Cash Funds|Company Cash and Cash Equivalents MDXH|LUCD (luciddx.com) - Company Cash Volume|Company Cash Funds PRE|Company Cash Volume IMDX|TRIB (Trinity Biotech PLC) - Company Cash Balance|Company Cash Volume PRPH (ProPhase Labs Corp)|AIMD: Company Cash and Cash Equivalents|codiagnostics.com - Company Cash Volume|heartsciences.com - Company Total Cash Amount|Biomerica Inc. (BMRA) - Company Cash Funds|Company Cash on Hand Cardio Diagnostics Holdings Inc.|ONCO (onconetix.gcs-web.com) - Company Cash Volume|Company Cash Funds BJDX|Company Cash on Hand AWH (aspirawh.com)|Company Cash on Hand acceleratediagnostics.com AXDX|Company Cash Volume CNTG (CENTOGENE N.V.)|ENZ: Company Cash and Cash Equivalents|FRES (fresh2.co) - Company Cash Reserve|GENE (gtglabs.com) - Company Cash and Cash Equivalents|ME: Company Cash Volume|PMD - Company Liquid Assets